|
Market Cap (17-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 12 January 2023, 8:25. The announcement is not marked as price sensitive, and is 2 page(s) in length and 213.01kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 1.635% short sold according to ASIC data. It was ranked the 146th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Notification of upcoming quarterly results and investor call | 12 January 2023, 8:25 |
| Webcast link correction - JP Morgan Conference Presentation | 10 January 2023, 12:58 |
| Notification of cessation of securities - TLX | 9 January 2023, 8:26 |
| JP Morgan Healthcare Conference Presentation | 9 January 2023, 8:20 |
You must be logged in to post a reply.
Telix Pharmaceuticals 